A strategic move or a ploy to arrest further shareholder wealth erosion?
08/07/24 -"The Grifols family and Brookfield have agreed to take Grifols private and should submit the bid in the coming weeks. This comes at an opportune time for the controlling shareholders since the shares ..."
Pages
53
Language
English
Published on
08/07/24
You may also be interested by these reports :
10/07/26
Astra’s cardiovascular drug, Wainua, failed a late-stage trial for a heart condition, and most of the drug’s $5bn peak sales expectations hinged on ...
07/07/26
Following the June 2026 phase III R&D setback for an investigational drug, Riliprubart, targeting a rare neurological disease called CIDP (chronic ...
06/07/26
Our target price has been adjusted downward as we have removed the 20% premium associated with peer-based valuation metrics. This adjustment is due ...
30/06/26
The recent US Supreme Court decision in the Roundup litigations, went in favour of Bayer, and brings the firm very close to ending this chapter. Even ...